Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jan;67(1):105–113.

Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.

Y Watanabe, H Kawakami, H Kawamoto, Y Ikemoto, K Masuda, E Takezaki, T Nakanishi, G Kajiyama, H Takeno
PMCID: PMC1542561  PMID: 3621670

Abstract

Using an autoimmune hepatitis model of A/J mice which was prepared with immunization by syngeneic crude liver proteins, various influences of neonatal thymectomy were studied by observations of histological liver changes, autoantibody to liver-specific membrane lipoprotein (LSP), delayed-type hypersensitivity (DTH) to LSP, and purified protein derivative (PPD), and suppressor activity to LSP. The liver changes in the thymectomized mice were more intense than those in the non-thymectomized controls. Production of the anti-LSP autoantibodies and positive DTH to syngeneic LSP could be recognized in both groups of the thymectomized mice and the non-thymectomized controls, but the levels of those were higher in the former. In the level of DTH to PPD the thymectomized mice were lower than the non-thymectomized controls. Adoptive transfer experiments showed that suppressor activity to LSP was reduced in the spleen cells of neonatally thymectomized mice. This experiment suggests that neonatal thymectomy is apt to abolish tolerance to LSP on account of depressed suppressor activity to autoantigen, and accordingly liver damage is increased.

Full text

PDF
105

Images in this article

109Fig. 3
on p.109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartholomaeus W. N., Reed W. D., Joske R. A. Autoantibody to liver-specific lipoprotein in the mouse: regulation by naturally occurring autoantigen specific suppressor cells. Clin Exp Immunol. 1984 Nov;58(2):307–316. [PMC free article] [PubMed] [Google Scholar]
  2. Büschenfelde K. H., Kössling F. K., Miescher P. A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin Exp Immunol. 1972 May;11(1):99–108. [PMC free article] [PubMed] [Google Scholar]
  3. Cantor H., Weissman I. Development and function of subpopulations of thymocytes and T lymphocytes. Prog Allergy. 1976;20:1–64. [PubMed] [Google Scholar]
  4. Cochrane A. M., Moussouros A., Thomsom A. D., Eddleston A. L., Wiiliams R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. doi: 10.1016/s0140-6736(76)91472-0. [DOI] [PubMed] [Google Scholar]
  5. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  6. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  7. Feighery C., McDonald G. S., Greally J. F., Weir D. G. Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease. Clin Exp Immunol. 1981 Jul;45(1):143–151. [PMC free article] [PubMed] [Google Scholar]
  8. Hopf U., Meyer zum Büschenfelde K. H., Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med. 1976 Mar 11;294(11):578–582. doi: 10.1056/NEJM197603112941103. [DOI] [PubMed] [Google Scholar]
  9. Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978 Jul 6;299(1):1–7. doi: 10.1056/NEJM197807062990101. [DOI] [PubMed] [Google Scholar]
  10. Kawauchi H., Shimamoto Y., Taniguchi K., Kubo C., Nomoto K. Differences in thymus dependency among the alloreactive T-cell subpopulations in their development. Cell Immunol. 1982 Jun;70(1):76–84. doi: 10.1016/0008-8749(82)90134-4. [DOI] [PubMed] [Google Scholar]
  11. Kawauchi H., Taniguchi K., Kubo C., Shimamoto Y., Nomoto K. The mechanism of reduction of cell-mediated cytotoxicity in neonatally thymectomized mice. Immunology. 1983 Oct;50(2):199–205. [PMC free article] [PubMed] [Google Scholar]
  12. Kuriki J., Murakami H., Kakumu S., Sakamoto N., Yokochi T., Nakashima I., Kato N. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae. Gastroenterology. 1983 Mar;84(3):596–603. [PubMed] [Google Scholar]
  13. Loblay R. H., Fazekas de St Groth B., Pritchard-Briscoe H., Basten A. Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med. 1983 Mar 1;157(3):957–973. doi: 10.1084/jem.157.3.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MILLER J. F. Immunological function of the thymus. Lancet. 1961 Sep 30;2(7205):748–749. doi: 10.1016/s0140-6736(61)90693-6. [DOI] [PubMed] [Google Scholar]
  15. McFarlane I. G., Wojcicka B. M., Zucker G. M., Eddleston A. L., Williams R. Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol. 1977 Mar;27(3):381–390. [PMC free article] [PubMed] [Google Scholar]
  16. Mori Y., Mori T., Yoshida H., Ueda S., Iesato K., Wakashin Y., Wakashin M., Okuda K. Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol. 1984 Jul;57(1):85–92. [PMC free article] [PubMed] [Google Scholar]
  17. Nishizuka Y., Sakakura T. Ovarian dysgenesis induced by neonatal thymectomy in the mouse. Endocrinology. 1971 Sep;89(3):886–893. doi: 10.1210/endo-89-3-886. [DOI] [PubMed] [Google Scholar]
  18. Popper H., Mackay I. R. Relation between Australia antigen and autoimmune hepatitis. Lancet. 1972 May 27;1(7761):1161–1164. doi: 10.1016/s0140-6736(72)91379-7. [DOI] [PubMed] [Google Scholar]
  19. Rose N. R., Kong Y. C., Sundick R. S. The genetic lesions of autoimmunity. Clin Exp Immunol. 1980 Mar;39(3):545–550. [PMC free article] [PubMed] [Google Scholar]
  20. Sakaguchi S., Takahashi T., Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982 Dec 1;156(6):1577–1586. doi: 10.1084/jem.156.6.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scheiffarth F., Warnatz H., Mayer K. Studies concerning the importance of mononuclear cells in the development of experimental hepatitis. J Immunol. 1967 Feb;98(2):396–401. [PubMed] [Google Scholar]
  22. Tremolada F., Fattovich G., Panebianco G., Ongaro G., Realdi G. Suppressor cell activity in viral and non-viral chronic active hepatitis. Clin Exp Immunol. 1980 Apr;40(1):89–95. [PMC free article] [PubMed] [Google Scholar]
  23. Uibo R. M., Helin H. J., Krohn K. J. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits. Clin Exp Immunol. 1982 May;48(2):505–512. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES